Ogena solution

Why puraclenz, why now?

ON A MISSION TO GET BACK TO BUSINESS

Ogena and Puraclenz are companies working to solve the world’s biggest health crisis in over a century. To help solve this problem, we’ve assembled an experienced product development, production and sales team who share a vision and commitment to develop viable solutions for businesses and homes across the globe.

Our mission is to get people back to business and provide them with enhanced protection from the virus that causes COVID-19 and its viral offspring. We can do this using Puraclenz’s patented technology to safely clean indoor air and surfaces continuously* and efficiently.

Ogena and Puraclenz are working together on something that has never been done before: providing added* protection against dangerous viruses and bacteria, safely, effortlessly, and at a low cost, to help people everywhere live healthier and more productive lives.

PARTNERING WITH PURACLENZ

Having worked with the people at Puraclenz over the past two years, Ogena has developed much respect for Puraclenz’s highly ethical business approach.

We are also incredibly proud to say that Ogena has an agreement with Puraclenz that allows us to be the Exclusive Master Distributor of Puraclenz’s commercial grade systems into the Animal Health Market in North America, and to be the Exclusive Master Distributor to all commercial markets in Canada.

Ogena will sell the Puraclenz systems under the OgenaShield umbrella of products, in keeping with our commitment to bring the latest and most efficacious products into the marketplaces we serve (as we did with the introduction and dramatic success of Virox Technologies Accelerated Hydrogen Peroxide Disinfectants into the animal health market).

We can say without question that the Puraclenz-developed products are a true game-changer in the world of biosecurity. When there is a need to control viruses and bacteria both in the air and on surfaces Puraclenz products offer a dramatic enhancement to traditional cleaning and disinfecting practices.

*Independently-conducted efficacy tests confirm, in typical indoor settings, that a Puraclenz P3000 unit is proven to be 98.85% effective in reducing the MS2 Bacteriophage (MS2) virus in the air.  MS2 is an approved surrogate (proxy) virus of SARS-CoV-2, the virus that causes COVID-19 due to the fact that is far more difficult to kill than all coronoviruses (including SARS-Cov-2, influenza, etc). The efficacy tests were performed by Aerosol Research and Engineering Laboratories in Olathe, Kansas, an FDA compliant laboratory.

In addition testing at Microbac Laboratories (also an FDA approved lab)  has shown that the P3000 unit was able to kill over 60% of the virus that causes Covid-19 on surfaces (SARS-Cov-2), something that HEPA and other traditional filtering systems simply cannot do.

HISTORY OF THE PURACLENZ TECHNOLOGY

Puraclenz’s next-gen indoor purification technology started more than 10 years ago when a friend of one of their founders lost his life due to a Hospital Acquired Infection (HAI) and related malpractice. This event inspired a research dive into the growing problem of HAIs and the mounting death toll of over 100,000 annual US hospital patients and an estimated 1 million deaths globally.

The need for a low-priced, safe, and powerful solution became the mandate for the founders of Puraclenz. Further research led to a small company in Denver, Colorado (UVAIRx, Inc.) that had new ideas for improving the power and safety of the well-documented and proven photocatalytic oxidation (PCO) technology: the same technology used by NASA in the International Space Station (ISS) to provide healthier air for astronauts. Puraclenz’ founders provided UVAIRx, Inc with a substantial investment, as well as technical and management assistance. UVAIRx, Inc spent seven years developing and market-testing a new proprietary technology, for which they later received a US Patent. Under an Asset Purchase Agreement, Puraclenz acquired this patent and hired its inventor, Jerrod Keith, as VP of R&D. Puraclenz continued to add additional proprietary features to the patent and commenced the commercial development and production of this next-generation version of PCO technology.

The Puraclenz management team (Wendell Minnick, Chris Dooley and Jerrod Keith) have nearly three decades of experience developing and bringing to market consumer and industrial products applying advanced materials and proprietary designs. The team has an extensive history of leading proprietary industrial and consumer product development with such partners as DuPont, Lockheed, Corning, iRobot and Kodak, as well as inventing and producing numerous proprietary consumer products protected by global patents.

Puraclenz’ re-invention of interior air purification is well-timed to provide a powerful, low-cost and safe solution to help business and families combat the current global pandemic and any future viral-based threats.

* When ran continuously as directed ** System is to be used in concert and as an adjunct to regular cleaning and disinfecting practices and is not intended to be a replacement for recognized biosecurity protocols.